Good Start Genetics is expanding VeriYou, its physician-ordered carrier screening tests, to include screening for Gaucher disease and…
Articles by Inês Martins, PhD
The sales of Elelyso for the treatment of Gaucher disease have increased significantly so far this year, Protalix BioTherapeutics announced…
The Assistance Fund is now providing financial assistance to help patients living with Gaucher disease (GD). The new fund will…
A new screening device called the Seeker System, which detects lysosomal storage disorders (LSDs) like Gaucher disease in newborns,…
The Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing…
Protalix BioTherapeutics has announced that Fundação Oswaldo Cruz (Fiocruz), an arm of the Brazilian Ministry of Health, has issued…
Protalix BioTherapeutics, a biopharma specializing in the development of recombinant therapeutic proteins, announced that the Brazilian National Health Surveillance…
Global Genes, a global advocacy nonprofit working for patients and families of rare and genetic diseases, will help hundreds…
Researchers at the Cairo University Pediatric Hospital, in Egypt and at the Baylor Research Institute in Dallas conducted a study…
Researchers at the Academic Medical Center Amsterdam in the Netherlands conducted a study with the aim of providing insight on the pathophysiological…